Drug Combination Details
General Information of the Combination (ID: C51704) | |||||
---|---|---|---|---|---|
Name | Epigallocatechin gallate NP Info | + | Temozolomide Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Brain cancer
[ICD-11: 2A00]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Augmenting Drug Sensitivity | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | HSPA5 | Molecule Info |
Pathway MAP
|
|
In-vitro Model | U-87MG ATCC | CVCL_0022 | Glioblastoma | Homo sapiens | ||
U-251MG | CVCL_0021 | Astrocytoma | Homo sapiens | |||
LN-229 | CVCL_0393 | Glioblastoma | Homo sapiens | |||
In-vivo Model | 2*105 cells (U87 and U251) in a volume of 10L were injected into the right frontal lobe of the brain and thereafter the skin incision was sutured with silk thread in athymic mice. | |||||
Experimental
Result(s) |
Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models. |
References | ||||
---|---|---|---|---|
Reference 1 | Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models. Cancer Lett. 2011 Mar 28;302(2):100-8. |
